Recently, it has been shown that the treatment of mice with IL-2/anti-IL-2 complex, generated by using JES6-1 antibody, increases the number of Tregs and protects from asthma, experimental autoimmune encephalomyelitis (EAE) and type 1 diabetes [22–24]. Here, IL2 is linked to asthma.